<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><volume>24</volume><submitter>Johannes Meyer</submitter><journal>Clinical cancer research : an official journal of the American Association for Cancer Research</journal><pagination>3325-3333</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/MODEL1909050002</full_dataset_link><repository>biostudies-other</repository><additional_accession>29463551</additional_accession><pubmed_authors>Johannes Meyer</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ribba2018 - Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy</name><description>&lt;notes xmlns="http://www.sbml.org/sbml/level2/version4">      &lt;body xmlns="http://www.w3.org/1999/xhtml">        &lt;pre>This is a model developed to predict concentrations of cergutuzumab amunaleukin (CEA-IL2v) after various systemic dosing intensities.&lt;/pre>      &lt;/body>    &lt;/notes></description><dates><release>2019-09-05T00:00:00Z</release><modification>2025-07-14T17:47:38.778Z</modification><creation>2025-03-30T22:48:08.387Z</creation></dates><accession>MODEL1909050002</accession><cross_references><pubmed>29463551</pubmed><ncit>C141459</ncit><mamo>MAMO_0000046</mamo><doi>10.1158/1078-0432.CCR-17-2953</doi></cross_references></HashMap>